Health Education Research Advance Access originally published online on October 6, 2009
Health Education Research 2009 24(6):941-948; doi:10.1093/her/cyp053
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Implementation fidelity of packaged teen smoking cessation treatments delivered in community-based settings
1 Institute of Public Health, College of Health and Human Sciences, Georgia State University, 140 Decatur Street, Room 878, Atlanta, GA 30303, USA
2 College of Public Health, Health Management and Policy, University of Iowa, 200 Hawkins Drive, E220H1 GH, Iowa City, IA 52242, USA
3 Institute for Health Research and Policy, University of Illinois at Chicago, 1747 West Roosevelt Rood, Room 558, Chicago, IL 60608, USA
* Correspondence to: K. Sterling. E-mail: ksterling{at}gsu.edu
Efficacious packaged teen smoking cessation treatment programs, those developed by national organizations, are widely disseminated to local communities to help teens quit smoking. The implementation fidelity of these programs in community settings has not been documented. The efficacy of these programs could be lessened if they are not implemented as intended. Data from Helping Young Smokers Quit describe the frequency and types of modifications made to packaged teen cessation treatment programs for community delivery. A national sample of 591 community-based teen tobacco cessation treatment programs was profiled and 59% used a single packaged treatment program. Bivariate analyses found that 63% of program administrators reported implementing their program as planned; 37% modified their selected program. The most frequently reported modifications were made to the length and format of the program. Of those who modified their programs, >90% reported multiple program modifications (e.g. length and content). Administrators modified their programs to accommodate implementation barriers, such as time constraints and low participant enrollment, and to address the needs of participants with multiple risk behaviors that are co-morbid with tobacco use.
Received on January 28, 2008; accepted on August 26, 2009